Effect of botulinum toxin A on Raynaud's phenomenon in patients with systemic sclerosis

Not Applicable

• Conditions: Raynaud' s phenomenon

• Registration Number: JPRN-UMIN000017617
• Lead Sponsor: Gunma University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-19
• Study Completion: 2015-08-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

Patients under the age 18, with the pregnancy or having the past medical histories with BTX-A were excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The change in severity of RP, including the frequency, pain, color and duration, by the Raynaud score and VAS at 4 weeks after treatment compared with the baseline.